Loading...
•
Jun 30, 2025
Atricure Q2 2025 Earnings Report
AtriCure reported strong second quarter 2025 financial results, exceeding expectations and raising its full-year financial outlook.
Key Takeaways
AtriCure delivered stellar second quarter 2025 results with worldwide revenue of $136.1 million, a 17.1% increase year-over-year. The company significantly improved its net loss and saw a substantial increase in Adjusted EBITDA, reflecting strong adoption of its products and therapies globally.
Worldwide revenue reached $136.1 million, marking a 17.1% increase year-over-year.
Net loss improved by $1.8 million year-over-year, totaling $6.2 million.
Adjusted EBITDA surged to $15.4 million, an increase of $7.6 million from the prior year.
The company generated $17.9 million in cash during the quarter and completed enrollment for the LeAAPS trial.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
AtriCure has raised its financial outlook for the full year 2025, projecting higher revenue and Adjusted EBITDA, along with modest cash flow generation.
Positive Outlook
- Full year 2025 revenue projected to be approximately $527 million to $533 million, an increase from previous guidance.
- Full year 2025 Adjusted EBITDA expected to be approximately $49 million to $52 million, indicating improved profitability.
- Management anticipates modest cash flow generation for the full year 2025.
- Continued strong adoption of products and therapies globally is expected to drive future growth.
- New technologies like AtriClip platform and cryoSPHERE device offerings are expected to drive deeper adoption and improved outcomes.
Challenges Ahead
- Full year 2025 adjusted loss per share is still expected to be in the range of $0.34 to $0.39, indicating continued non-GAAP losses.
- Gross margin decreased by 15 basis points from the prior year, reflecting less favorable geographic and product mix.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...